📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vtesse Pharma

1.1 - Company Overview

Vtesse Pharma Logo

Vtesse Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of rare disease drug development for underserved patients, working collaboratively to advance VTS-270, which has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease; first spin-out of Cydan Development, Inc., an orphan-drug accelerator.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vtesse Pharma

Sobi Logo

Sobi

HQ: Sweden Website
  • Description: Provider of orphan and specialty pharmaceuticals for rare and life-threatening diseases, developing, marketing and distributing treatments across haematology, cardiology, infectious and metabolic disorders, genetic diseases, and conditions in immunocompromised patients; portfolio includes Alprolix, Elocta, Synagis, Kineret, Orfadin, and Gamifant.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sobi company profile →
Azafaros Logo

Azafaros

HQ: The Netherlands Website
  • Description: Provider of oral azasugar-based therapeutic agents targeting rare lysosomal storage disorders, including the investigational small molecule nizubaglustat for GM1 and GM2 gangliosidoses and Niemann-Pick disease type C. Offers the PRONTO natural history study and the RAINBOW clinical study evaluating nizubaglustat, plus an expanded access policy for AZ-3102 limited to clinical trial participation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azafaros company profile →
Synageva BioPharma Logo

Synageva BioPharma

HQ: United States Website
  • Description: Provider of novel, next generation and follow on protein therapeutics developed and commercialized using the proprietary Synageva Expression Platform (SEPTM).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synageva BioPharma company profile →
CombiGene Logo

CombiGene

HQ: Sweden Website
  • Description: Provider of novel gene therapies addressing severe life-altering diseases lacking adequate treatment; developing CG01, an AAV-based therapy for drug-resistant focal epilepsy, and COZY01, a gene therapy for severe chronic pain in collaboration with Zyneyro; previously pursued CGT2 for partial lipodystrophy (discontinued).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CombiGene company profile →
Orphazyme Logo

Orphazyme

HQ: Denmark Website
  • Description: Provider of biopharmaceutical R&D for novel therapeutics targeting lysosomal storage diseases and other genetic disorders; conducts clinical trials, offers early access programs for investigational drugs, and delivers safety reporting/pharmacovigilance. Developed arimoclomol for neurodegenerative diseases, including Niemann Pick disease type C (sold to KemPharm Denmark A/S).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orphazyme company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vtesse Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vtesse Pharma

2.2 - Growth funds investing in similar companies to Vtesse Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vtesse Pharma

4.2 - Public trading comparable groups for Vtesse Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vtesse Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vtesse Pharma

What does Vtesse Pharma do?

Vtesse Pharma is a provider of rare disease drug development for underserved patients, working collaboratively to advance VTS-270, which has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease; first spin-out of Cydan Development, Inc., an orphan-drug accelerator.

Who are Vtesse Pharma's competitors?

Vtesse Pharma's competitors and similar companies include Sobi, Azafaros, Synageva BioPharma, CombiGene, and Orphazyme.

Where is Vtesse Pharma headquartered?

Vtesse Pharma is headquartered in United States.

How many employees does Vtesse Pharma have?

Vtesse Pharma has 1,000 employees 🔒.

When was Vtesse Pharma founded?

Vtesse Pharma was founded in 2010 🔒.

What sector and industry vertical is Vtesse Pharma in?

Vtesse Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vtesse Pharma

Who are the top strategic acquirers in Vtesse Pharma's sector and industry

Top strategic M&A buyers and acquirers in Vtesse Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vtesse Pharma?

Top strategic M&A buyers groups and sectors for Vtesse Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vtesse Pharma's sector and industry vertical

Which are the top PE firms investing in Vtesse Pharma's sector and industry vertical?

Top PE firms investing in Vtesse Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vtesse Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vtesse Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vtesse Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vtesse Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vtesse Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vtesse Pharma?

The key public trading comparables and valuation benchmarks for Vtesse Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vtesse Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vtesse Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vtesse Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vtesse Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vtesse Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Vtesse Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vtesse Pharma